Lobbying Information
Subject Matters
- Consumer Issues
- Economic Development
- Federal-Provincial Relations
- Health
- International Development
- Regional Development
- Research and Development
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.
Policies or Program
- Representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in Canada. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the drug plans administered by the Federal Government and to emphasize the importance that the federal government respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs.
- To actively promote the enhancement of publicly funded women’s health initiatives/programs.
- To actively promote the value of the pharmaceutical industry for Canada's economic health and well being, but more importantly for the health and well being of its citizens and to propose solutions for integrated health care in Canada.
- To recommend policies that will attract increased investment in the pharmaceutical and well being industry, such as on policies, research programs and policies and the Innovation Agenda.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Health Canada (HC)
-
House of Commons
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Women and Gender Equality (WAGE)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
16766 Transcanadienne, Canada
Kirkland, QC H9H 4M7
Canada
Telephone number:
800-387-1326
Web address:
https://www.organon.com/canada-fr/
Client representative
Geneviève Gauthier, Directrice associée, politique santé & accès
Parent Company Information
- Organon & Co., Inc. / Organon & Co., Inc.
-
30 Hudson St
Jersey City, NJ 07302
United States of America
Coalition Members Information
Organon Canada Inc. / Organon Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Organon Canada Inc. / Organon Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Organon Canada Inc. / Organon Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Francois de Le Rue
|
Public offices held
Business address:
1410, rue Stanley Street, Suite 1010
Montréal, QC H3A 1P8
Canada
Telephone number:
581-995-6186
Consultant Firm and Address
Firm:
Teneo / Teneo
Address:
1410, rue Stanley Street, Suite 1010
Montréal, QC H3A 1P8
Canada
Telephone number:
581-995-6186
